研究發展處

Neuroscience

1. Migraine 100%
2. Functional Magnetic Resonance Imaging 72%
3. Functional Connectivity 72%
4. Alzheimer's Disease 70%
5. Headache 64%
6. Electroencephalogram 43%
7. Cognitive Disorders 40%
8. Behavior (Neuroscience) 39%
9. Gray Matter Volume 37%
10. Cognitive Function 36%
11. Major Depressive Disorder 36%
12. Magnetic Resonance Imaging 35%
13. Cerebrovascular Accident 35%
14. Hippocampus 33%
15. Parkinson's Disease 32%
16. Magnetic Resonance Imaging 31%
17. Mild Cognitive Impairment 31%
18. In Vivo 29%
19. Heart Rate Variability 26%
20. Brain Network 25%
21. Diffusion Tensor Imaging 25%
22. Amygdala 24%
23. Thalamus 22%
24. Blood Plasma 21%
25. Cerebellum 21%
26. Striatum 21%
27. Gray Matter 21%
28. Receptor 19%
29. Obstructive Sleep Apnea 19%
30. Default Mode Network 18%
31. Antidepressant 17%
32. Glutamic Acid 16%
33. Voxel-Based Morphometry 16%
34. Fractional Anisotropy 16%
35. Electrotherapy 16%
36. Tractography 16%
37. Longitudinal Study 15%
38. Mental Disorder 15%
39. Nociception 15%
40. Sleep Quality 15%
41. Brain Ischemia 15%
42. Magnetoencephalography 15%
43. Evoked Potential 15%
44. Fluorine-18 15%
45. Gyri 14%
46. Pervasive Developmental Disorder 14%
47. Orbitofrontal Cortex 14%
48. Frontal Lobe 14%
49. Gamma-Aminobutyric Acid 14%
50. Depressive Disorder 13%
51. Neural Network 13%
52. Brain-Computer Interface 13%
53. Cluster Headache 13%
54. Positron Emission Tomography 13%
55. Comorbidity 13%
56. Brain-Derived Neurotrophic Factor 13%
57. Cerebrovascular Disease 13%
58. Prefrontal Cortex 12%
59. Putamen 12%
60. Transcranial Magnetic Stimulation 12%
61. Amyloid Protein 12%
62. Attention Deficit Hyperactivity Disorder 12%
63. In Vitro 12%
64. Hypertension 11%
65. Medication Overuse 11%
66. Neurodegenerative Disorder 11%
67. Dopaminergic 11%
68. Corpus Callosum 11%
69. Programmed Cell Death 11%
70. Temporal Lobe 11%
71. Oxidative Stress 11%
72. Nervous System Disorder 11%
73. Brain Areas 11%
74. Subjective Cognitive Decline 10%
75. Metabolic Pathway 10%
76. Brain Disease 10%
77. Somatosensory Cortex 10%
78. Gene Expression 10%
79. Neural Stem Cell 10%
80. Anterior Cingulate Cortex 10%
81. Astrocyte 10%
82. Neuronal Activity 10%
83. Posterior Cingulate 10%
84. Ketamine 10%
85. Anxiety Disorder 10%
86. Stem Cell 9%
87. Bipolar Disorder 9%
88. Precuneus 9%
89. Epoxide Hydrolase 9%
90. Cingulate Cortex 9%
91. Interneuron 9%
92. Auras 9%
93. Executive Function 9%
94. Cerebral Cortex 9%
95. Huntington's Disease 9%
96. Neuronal Migration 9%
97. Mouse Brain 8%
98. Fibromyalgia 8%
99. Ischemia 8%
100. Sleep Disorder 8%

Keyphrases

1. Migraine 73%
2. Taiwan 66%
3. Alzheimer's Disease 60%
4. Functional Connectivity 47%
5. Chronic Migraine 44%
6. Functional Magnetic Resonance Imaging 42%
7. Electroencephalography 40%
8. Healthy Controls 38%
9. Major Depressive Disorder 36%
10. Gray Matter Volume 36%
11. Schizophrenia 34%
12. Headache 32%
13. Cognitive Function 32%
14. Taiwanese 31%
15. Magnetoencephalography 29%
16. Parkinson's Disease 29%
17. Cognitive Impairment 28%
18. Brain Regions 28%
19. Reversible Cerebral Vasoconstriction Syndrome 28%
20. Mild Cognitive Impairment 26%
21. Resting-state Functional Magnetic Resonance Imaging (rs-fMRI) 26%
22. Confidence Interval 23%
23. Diffusion Tensor Imaging 22%
24. Hippocampus 22%
25. Dementia 22%
26. Brain-computer Interface 21%
27. Older Adults 21%
28. Heart Rate Variability 21%
29. Magnetic Resonance Imaging 21%
30. National Cohort Study 20%
31. Striatum 20%
32. Migraine Patients 20%
33. Electroencephalogram 18%
34. Cluster Headache 18%
35. Obstructive Sleep Apnea 18%
36. Default Mode Network 18%
37. Resting State 17%
38. Neuroimaging 15%
39. Voxel-based Morphometry 15%
40. Autism Spectrum Disorder 15%
41. Attention Deficit Hyperactivity Disorder 15%
42. Amygdala 15%
43. Fractional Anisotropy 15%
44. Cerebellum 14%
45. Human Brain 14%
46. White Matter 14%
47. Brain Activity 14%
48. Pathophysiology 13%
49. Cognitive Decline 13%
50. Odds Ratio 13%
51. Aging 13%
52. Age-related 13%
53. Positron Emission Tomography 12%
54. Brain Networks 12%
55. Oxidative Stress 12%
56. Episodic Migraine 12%
57. Sleep Quality 12%
58. Striatal 12%
59. Neurodegenerative Diseases 12%
60. Subjective Cognitive Decline 12%
61. Protein Kinase 11%
62. Hazard Ratio 11%
63. Healthy Adults 11%
64. Steady-state Visual Evoked Potential (SSVEP) 11%
65. White Matter Hyperintensities 11%
66. Medication Overuse Headache 11%
67. Single nucleotide Polymorphism 11%
68. Schizophrenic Patients 11%
69. Proteomic Analysis 11%
70. Anterior Cingulate Cortex 11%
71. Mini-Mental State Examination 11%
72. Hepatocellular Carcinoma 11%
73. Rat Model 11%
74. Bipolar Disorder 11%
75. Psychiatric Disorders 11%
76. Ischemic Stroke 10%
77. Cognitive Performance 10%
78. Taiwan Biobank 10%
79. Aging Effect 10%
80. Cortex 10%
81. CISD2 10%
82. Resting-state Functional Connectivity (rs-FC) 10%
83. Brain Structure 10%
84. Induced Pluripotent Stem Cells (iPSCs) 10%
85. Hypertension 10%
86. MRI Study 10%
87. Neural Stem Cells 9%
88. Brain Connectivity 9%
89. Population-based Retrospective Cohort Study 9%
90. Sensory Gating 9%
91. Neural Correlates 9%
92. Cell Migration 9%
93. Primary Dysmenorrhea 9%
94. Cerebral Small Vessel Disease (cSVD) 9%
95. Anxiety-depression 9%
96. Antidepressants 9%
97. Treatment-resistant Depression 9%
98. Soluble Epoxide Hydrolase 9%
99. Intracranial Hypotension 9%
100. Ketamine 9%